Spyre Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 90.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 45.2M | 45.2M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 45.2M | -45.2M | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 60.4M | 44.6M | 45.2M | 40.1M | 41.6M | 50.5M | 44.7M | 32.6M |
| Operating Expenses | 75.6M | 102.4M | 11.6M | 41.9M | 53.6M | 61.3M | 55.4M | 44.1M |
| Operating Income | -75.6M | -57.2M | -56.9M | -41.9M | -53.6M | -61.3M | -55.4M | -44.1M |
| Other Income / Gains | 6.6M | -5.4M | 45.7M | 5.2M | 8.8M | 5.0M | -13.6M | 5.3M |
| Net Income | -69.0M | -62.5M | -11.2M | -36.7M | -44.8M | -56.3M | -69.0M | -38.8M |
| EPS (Diluted) | -0.74 | -0.69 | -0.15 | -0.60 | -0.13 | -0.15 | -1.36 | -0.86 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0.50 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 15.2M | 12.5M | 11.6M | 11.8M | 11.9M | 10.8M | 10.6M | 11.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 15.2M | 12.5M | 11.6M | 11.8M | 11.9M | 10.8M | 10.6M | 11.5M |
| Other Expenses | 0 | 45.2M | -45.2M | -10.0M | 0 | 0 | 0 | 0 |
| Cost And Expenses | 75.6M | 147.7M | 56.9M | 41.9M | 53.6M | 61.3M | 55.4M | 44.1M |
| Interest Income | 7.0M | 7.1M | 5.4M | 5.9M | 6.5M | 5.8M | 5.2M | 5.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ebitda | -75.6M | -62.5M | -11.2M | -51.9M | -53.6M | -61.3M | -55.4M | -44.1M |
| Ebitdaratio | 0 | -0.691 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | -0.632 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -69.0M | -62.5M | -11.2M | -36.7M | -44.8M | -56.3M | -69.0M | -38.8M |
| Income Before Tax Ratio | 0 | -0.691 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | -15K | 1K | 18K | 0 |
| Net Income Ratio | 0 | -0.691 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.74 | -0.70 | -0.15 | -0.60 | -0.13 | -0.15 | -1.36 | -0.86 |
| Weighted Average Shs Out | 346.0M | 346.0M | 74.9M | 60.7M | 60.3M | 47.0M | 50.9M | 45.3M |
| Weighted Average Shs Out Dil | 346.0M | 346.0M | 60.4M | 60.7M | 60.3M | 47.0M | 50.9M | 45.3M |